Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |